Acura Pharmaceuticals, Inc. (ACUR)

Market Cap	26.66K -91.9%
Revenue (ttm)	1.56M -56.2%
Net Income	-879.00K
EPS	-0.02
Shares Out	66.65M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	400
Average Volume	4,439
Open	0.0004
Previous Close	0.0004
Day's Range	0.0004 - 0.0004
52-Week Range	0.0001 - 0.0200
Beta	58.62
RSI	48.14
Earnings Date	n/a

About Acura Pharmaceuticals

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1935
• Employees: 9
• Stock Exchange: OTCMKTS
• Ticker Symbol: ACUR